Ambry Genetics
在场
Ambry Genetics 的所有者是 Konica Minolta.
是其中之一......
Konica Minolta 是一家在股票代码 4902 (JP) 下上市的公司。
Konica Minolta 在 12 个国家有直接业务。Konica Minolta 拥有 16家子公司，其中包括 Ambry Genetics、Invicro 和 Konica Minolta Australia。
他们在：
高管
查看带有其 8 名主要高管的组织结构图
Ambry Genetics 搜索最多的简介
- Tom Schoenherr, Chief Executive Officer
- Kiyotaka Fujii, President
- Brigette Davis, Chief Operating Officer
高管在Konica Minolta变化
- Yusuke Yoshimura 曾任 Corporate Senior Vice President, General Manager, FORXAI Business Operations, 将于 20243月31 现任 Senior Vice President and Executive Officer, Imaging Solution Business (新闻发布的2024三月5号).
- Hiroyuki Uemura 曾任 Deputy General Manager, Quality Management Headquarters, 将于 20243月31 现任 Senior Vice President and Executive Officer, Corporate Quality Management (新闻发布的2024三月5号).
- Ken Osuga 曾任 Corporate Senior Vice President, Strategic Project, 将于 20243月31 现任 Senior Vice President and Executive Officer, Business Development, Business Technologies (新闻发布的2024三月5号).
创建提醒
跟踪 Ambry Genetics 的高管变动
生物技术
Konica Minolta 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Evommune 刚刚宣布为 115 筹款数百万美元。 (公布2024十一月4号).
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
生物技术 行业的其他推荐联系人
消息
Ambry Genetics 的最新新闻稿
- Ambry Genetics Announces New Hereditary Cancer Test Menu at NSGC Annual Conference
- Ambry Genetics Announces New Multiomic Exome Test for Improved Rare Disease Detection
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
- Ambry Genetics Announces a Collaboration with Tempus to Advance Paired Germline and Somatic Testing Services for Medical Oncologists
- Ambry Genetics Unveils at ASHG New Insights on the Use of Multiomic Testing in 43,000 Patient Study
- Unilabs and Ambry Sign Agreement to Enhance Genetic Testing Services for Biopharma Companies in Europe, Latin America and the Middle East
- Ambry Genetics Publishes 43,000 Patient Study Showing Combined RNA and DNA Analysis Identifies Patients Who Are High-Risk for Cancer but Would Have Been Missed by DNA Testing Alone
- Konica Minolta Precision Medicine Announces Name Change to REALM IDx™ - Press Release | Ambry Genetics
- PRECEDE Consortium Announces Konica Minolta Precision Medicine as its Precision Health Partner to Advance its Mission to Increase Survival Rates for Patients with Pancreatic Cancer - Press Release | Ambry Genetics
- Ambry Genetics Leads in Clinical Contributions to GenCC, a Public Database to Inform the Relationship Between Various Genes and Diseases - Press Release | Ambry Genetics
- View more press releases Close
通过电子邮件
